<bill session="119" type="h" number="796" updated="2025-07-28T15:24:41Z">
  <state datetime="2025-01-28">REFERRED</state>
  <status>
    <introduced datetime="2025-01-28"/>
  </status>
  <introduced datetime="2025-01-28"/>
  <titles>
    <title type="display">Second Chance for Moms Act</title>
    <title type="short" as="introduced">Second Chance for Moms Act</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001211"/>
  <cosponsors>
    <cosponsor bioguide_id="B001291" joined="2025-01-28"/>
    <cosponsor bioguide_id="B001325" joined="2025-04-01"/>
    <cosponsor bioguide_id="C001116" joined="2025-01-28"/>
    <cosponsor bioguide_id="H001052" joined="2025-01-28"/>
    <cosponsor bioguide_id="H001102" joined="2025-02-04"/>
    <cosponsor bioguide_id="M001212" joined="2025-01-28"/>
    <cosponsor bioguide_id="M001235" joined="2025-01-28"/>
    <cosponsor bioguide_id="O000175" joined="2025-01-28"/>
    <cosponsor bioguide_id="P000609" joined="2025-02-06"/>
    <cosponsor bioguide_id="R000612" joined="2025-02-26"/>
    <cosponsor bioguide_id="T000478" joined="2025-01-28"/>
    <cosponsor bioguide_id="W000814" joined="2025-01-28"/>
    <cosponsor bioguide_id="W000806" joined="2025-01-28"/>
  </cosponsors>
  <actions>
    <action datetime="2025-01-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-01-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Abortion"/>
    <term name="Consumer affairs"/>
    <term name="Prescription drugs"/>
    <term name="Sex and reproductive health"/>
    <term name="Telephone and wireless communication"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary date="2025-07-28T15:23:35Z" status="Introduced in House">Second Chance for Moms Act of 2025

This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)</summary>
</bill>
